- Why You Should Play the Reflation Trade: Stock Picker
- S&P to Hit 1,200 by Year-End: Chief Investor
- 5 Big Bank Stocks Investors Should Consider: Strategists
- My 2010 Home Price Outlook: UBS Analyst
- Why Are Options Piling into Dollar Tree?
- Markets Can Rise 5-10% in the Near-Term: Strategist
- Buy These 'Competitively Positioned' Stocks: Portfolio Manager
- 5 Stocks That Benefit from Health Care Legislation: Analysts
- 9 Stocks That Play Rising Water Costs: Strategists
- Gold Prices Can Double in 3 Years: Portfolio Manager
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Amended Berkshire Hathaway Filing Indicates No Secret Stock Stakes at End of Q3
- CNBC Anchor Takes a Sabbatical
- Privately Held Facebook Creates Dual-Class Stock
- NBA D-League On The Rise
- On Twitter, Beware False Prophets
- Busch: The Debt-Interest Rate Paradox
- Just In Time for Holidays: More Gloom and Doom on Economy
- Oil Tomorrow
- Citi Mortgage Reveals What Treasury Won't
- Citi Mortgage Reveals What Treasury Won't
- S&P to Hit 1,200 by Year-End: Chief Investor
- Amended Berkshire Hathaway Filing Indicates No Secret Stock Stakes at End of Q3
- Facebook's Biggest-Ever Holiday Shopping Season
- Facebook's New Dual Class Structure - Slow Steps to an IPO
- 5 Big Bank Stocks Investors Should Consider: Strategists
- Gambling Drunk, Texting to Live And America's On Sale - Your Emails
- Nov. 24: Unusual Volume Leaders
- NBA D-League On The Rise
- US Firms Hit by Payroll Taxes at Exactly the Wrong Time
- Citi Mortgage Reveals Something the US Treasury Won't
- Fed Sanguine About US Recovery, Worried on Jobs
- Amended Berkshire Filing Reveals No 'Secret' Holdings
- In Time for Holidays: More Gloom and Doom on Economy
- Market Pros Reveal Top Black Friday Trades
- Turkey Day 101: How Well Do You Know Your Bird?
- Privately Held Facebook Creates Dual-Class Stock
- Holiday Guide to This Season's Smartphones
RSS FEED
CNBC Stock Blog
Text Size 
Deals may have slowed down, but M&A ain't dead.
Big mergers and acquisitions across sectors including biotech and pharma, tech, materials and manufacturing are coming to pass. And high-profile combinations including Roche and Genentech [DNA
Loading...
()
], Dow Chemical [DOW
Loading...
()
] and Rohm & Haas [ROH
Loading...
()
] are expected to close soon.
Roche finally has a sufficient war chest of "enormous amounts of capital" which it raised in the U.S. and Europe, reports CNBC's David Faber. The Swiss drug maker now holds 93.2 percent of Genentech, with 3 percent of the latter's outstanding shares "guaranteed to be delivered within three business days."
Watch the video above for Faber's full report.
_________________________________
More from CNBC:
_________________________________
_________________________________
Data is a real-time snapshot *Data is delayed at least 15 minutes